Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (13C) as a Diagnostic and Response Monitoring Imaging Tool in Advanced Prostate Cancer

NCT04346225 is registered in ClinicalTrials.gov with Ivan de Kouchkovsky, MD as lead sponsor.

NCT NCT04346225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04346225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (13C) as a Diagnostic and Response Monitoring Imaging Tool in Advanced Prostate Cancer
Lead sponsor
Ivan de Kouchkovsky, MD
Phase
Phase 2
Overall status
Suspended
Start date
July 16, 2020
Completion date
November 30, 2027
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced prostate carcinoma, prostate cancer